Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Prod # User-agent: * # Disallow: |
Title | OLINVYK® (oliceridine) - The Most Recently Approved IV Opioid | For |
Description | Prioritize pain OLINVYK® CII is indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. See Safety |
Keywords | N/A |
WebSite | olinvyk.com |
Host IP | 205.186.187.219 |
Location | United States |
Site | Rank |
US$6,992,099
Last updated: 2023-05-11 11:38:47
olinvyk.com has Semrush global rank of 1,513,752. olinvyk.com has an estimated worth of US$ 6,992,099, based on its estimated Ads revenue. olinvyk.com receives approximately 806,781 unique visitors each day. Its web server is located in United States, with IP address 205.186.187.219. According to SiteAdvisor, olinvyk.com is safe to visit. |
Purchase/Sale Value | US$6,992,099 |
Daily Ads Revenue | US$6,455 |
Monthly Ads Revenue | US$193,628 |
Yearly Ads Revenue | US$2,323,529 |
Daily Unique Visitors | 53,786 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
olinvyk.com. | A | 7200 | IP: 205.186.187.219 |
olinvyk.com. | NS | 7200 | NS Record: ns39.worldnic.com. |
olinvyk.com. | NS | 7200 | NS Record: ns40.worldnic.com. |
olinvyk.com. | TXT | 7200 | TXT Record: g7ho6ghcb01co7htkn6ape9ej8 |
olinvyk.com. | TXT | 7200 | TXT Record: mt-98304153 |
This site is intended for US healthcare professionals only. PATIENT PROFILES EFFICACY SAFETY KOL PERSPECTIVES DOSING ORDERING GET CONNECTED PRESCRIBING INFORMATION MENU PATIENT PROFILES EFFICACY SAFETY KOL PERSPECTIVES DOSING ORDERING GET CONNECTED PRESCRIBING INFORMATION Prioritize pain relief Prioritize pain relief Rapid onset Median onset of pain relief 1-3 minutes after initial dose 1 * Safety and tolerability Well-established safety and tolerability profile, including safety data in patients at risk for ORAEs 1,2 † Predictable analgesia No active metabolites—reduces dose stacking concerns 1,3,4 Flexible dosing No dosage adjustment for renal impairment. Bolus dosing 1-3 hours. PCA option also available 1,3 † L earn more about OLINVYK Explore profiles of patients who could benefit from an advanced IV opioid. PATIENT PROFILES Find safety and tolerability data from clinical trials. SAFETY Hear from today’s key opinion leaders on the challenges of acute pain management in the OLINVYK |
HTTP/1.1 301 Moved Permanently Date: Thu, 04 Nov 2021 16:29:54 GMT Server: Apache/2.4.39 Location: https://olinvyk.com/ Cache-Control: max-age=0 Expires: Thu, 04 Nov 2021 16:29:54 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 server: nginx/1.16.1 date: Thu, 04 Nov 2021 16:29:54 GMT content-type: text/html; charset=utf-8 content-length: 27741 last-modified: Wed, 13 Oct 2021 16:11:59 GMT accept-ranges: bytes cache-control: max-age=0 expires: Thu, 04 Nov 2021 16:29:54 GMT vary: Accept-Encoding,User-Agent x-ua-compatible: IE=edge x-content-type-options: nosniff |
Domain Name: OLINVYK.COM Registry Domain ID: 2279765460_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-04-28T07:43:25Z Creation Date: 2018-06-27T18:03:30Z Registry Expiry Date: 2022-06-27T18:03:30Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS39.WORLDNIC.COM Name Server: NS40.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-22T08:13:03Z <<< |